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EDITORIALThe Gut Microbiota, Intestinal Permeability, Bacterial
Translocation, and Nonalcoholic Fatty Liver Disease:
What Comes First?onalcoholic fatty liver disease (NAFLD) is one of theNleading causes of chronic liver disease in the United
States, and its prevalence is rising in the developed as well
as in the developing world.1 Although tremendous headway
has been made in understanding the pathogenesis of
NAFLD, the role of the gut microbiota and intestinal
permeability in augmenting disease progression from
nonalcoholic fatty liver (NAFL), the nonprogressive form of
NAFLD, to nonalcoholic steatohepatitis (NASH), the pro-
gressive form of NAFLD, remains incompletely understood.
In the current issue of Cellular and Molecular Gastroen-
terology and Hepatology, Luther et al2 evaluate the associ-
ation between NAFLD and increased intestinal permeability.
A higher prevalence of increased intestinal permeability has
been seen in patients with obesity or NAFLD, with some
studies suggesting a role in the pathogenesis of NAFLD.3–6
Through a meta-analysis of ﬁve such studies, Luther et al
found that almost 40% of patients with NAFLD had
increased intestinal permeability. In contrast, only 6.8% of
healthy controls demonstrated these changes. A subgroup
analysis of NASH patients showed a stronger association
with altered intestinal permeability, with nearly 50%
affected, suggesting that the necroinﬂammatory changes
seen in NASH may be more closely associated with
increased gut permeability.
Previous studies have tried to explain the association
between intestinal permeability and NAFLD. In an experi-
mental model of NASH, Gäbele et al7 were able to propagate
liver injury and inﬂammation by inducing colitis. They hy-
pothesized that injury to the intestinal epithelium led to
increased permeability and passage of bacterial products to
the portal vein, leading to enhanced liver injury. Others have
shown that obesity itself may lead to altered intestinal
permeability through an increase in tumor necrosis factor-a
(TNFa) levels and increased intestinal inﬂammation.8,9
Furthermore, it has been found that the intestinal micro-
biome is perturbed in both obesity and NAFLD, which may
lead to changes in microbial products and a resultant leaky
gut.5,10,11
In their study, Luther et al2 have taken another approach
to explain this association by hypothesizing that liver injury
may precede the development of increased intestinal
permeability. They suggest that an initial liver injury may
lead to the release of inﬂammatory cytokines, which in turn
affects the intestinal tight junctions and increases intestinal
permeability passage of bacterial elements into the portal
circulation propagating the preexisting liver injury. To
evaluate this hypothesis, they chose a dietary model in
which mice rapidly develop steatosis and inﬂammationCelluwhen fed a methionine and choline deﬁcient (MCD) diet.
They sacriﬁced mice at different time points and measured
both serum and hepatic levels of TNFa, interleukin-6 (IL-6),
and IL-1b, as well as noted the timeline of development of
liver steatosis and inﬂammation. They then made serial
measures of intestinal permeability using a previously
veriﬁed technique.
The data showed that the systemic and hepatic levels of
TNFa and alanine aminotransferase followed a similar
timeline, with an initial rise around day 6 and a subsequent
peak at day 21. The histologic changes of NASH, quantiﬁed
using a modiﬁed NAFLD activity score, paralleled these
biochemical changes. Other indicators of inﬂammation,
including levels of the cytokines IL-6 and IL-1b, did not
show signiﬁcant changes during this period. Interestingly,
increases in intestinal permeability could not be detected
until after initial damage to the liver had been identiﬁed,
suggesting that, at least in this model, leaky gut could not be
blamed for the initial insult to the liver. Immunoﬂuores-
cence microscopy of the small intestines demonstrated
disruption of zona occludens-1 on day 10, consistent with
the idea that epithelial tight junction injury occurred after
the initial liver injury.
Direct incubation of hepatocytes with MCD medium led
to steatosis, inﬂammation, and an increase in TNFa, but
incubation of intestinal cells did not lead to alteration of
tight junctions or intestinal permeability in vitro. This sug-
gests that the MCD diet was sufﬁcient to cause liver injury
but did not directly injure the intestines. Luther et al2 hy-
pothesized that intestinal injury in this model may be a
consequence of liver injury, probably through release of
systemic cytokines such as TNFa. To test this, they per-
formed similar experiments in MLCK (myosin light chain
kinase) mice, which are resistant to acute TNFa-induced
intestinal permeability. Feeding these mice the MCD diet led
to similar liver and intestinal changes, arguing against TNFa
production as the primary mechanism of intestinal tight
junction changes in this model.
Although the MCD murine model has been widely used
to study NASH, it has some notable limitations that should
be considered to put the results of Luther et al2 in
perspective. As opposed to what we see in human NAFLD,
mice fed the MCD diet do not show features of metabolic
syndrome such as obesity, insulin resistance, or dyslipide-
mia. Therefore, these results need to be validated in other
animal models that more closely mimic human NAFLD such
as the high-fat diet mouse model. Furthermore, the conclu-
sion that increased intestinal permeability is not related to
TNFa needs to be validated in humans. TNFa, IL-6, andlar and Molecular Gastroenterology and Hepatology 2015;1:129–130
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NAFLD through pathways not applicable to the mouse
model. On the other hand, ﬁndings from the MCD mouse
model raise the interesting possibility that the increased
intestinal permeability seen in NAFLD may be, at least in
part, independent of the obesity phenotype.
A strength of this study is the use of clinical meta-
analytic methods as a means of developing a rationale to
support the mechanistic experimental study using a mouse
model. The evaluation of the published literature together
with the insights gathered from the mouse work further
strengthens the association between NAFLD and increased
intestinal permeability, and the study by Luther et al2 pro-
vides key data to further our understanding of the role of
altered gut permeability in the pathogenesis of NAFLD.
Prospective clinical studies using well-characterized pa-
tients are needed to examine whether hepatic steatosis is
associated with further increases in gut permeability above
and beyond that seen in obesity. Future research should
examine whether alterations in intestinal permeability and
the nature of the gut microbiota can predict disease pro-
gression from NAFL to NASH to cirrhosis.
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